APA (7th ed.) Citation

Archer, D. F., Labrie, F., Montesino, M., & Martel, C. (2017). Comparison of intravaginal 6.5 mg (0.50%) prasterone, 0.3 mg conjugated estrogens and 10 μg estradiol on symptoms of vulvovaginal atrophy. Journal of Steroid Biochemistry & Molecular Biology, 174, 1. https://doi.org/10.1016/j.jsbmb.2017.03.014

Chicago Style (17th ed.) Citation

Archer, David F., Fernand Labrie, Marlene Montesino, and Céline Martel. "Comparison of Intravaginal 6.5 Mg (0.50%) Prasterone, 0.3 Mg Conjugated Estrogens and 10 μg Estradiol on Symptoms of Vulvovaginal Atrophy." Journal of Steroid Biochemistry & Molecular Biology 174 (2017): 1. https://doi.org/10.1016/j.jsbmb.2017.03.014.

MLA (9th ed.) Citation

Archer, David F., et al. "Comparison of Intravaginal 6.5 Mg (0.50%) Prasterone, 0.3 Mg Conjugated Estrogens and 10 μg Estradiol on Symptoms of Vulvovaginal Atrophy." Journal of Steroid Biochemistry & Molecular Biology, vol. 174, 2017, p. 1, https://doi.org/10.1016/j.jsbmb.2017.03.014.